Advertisement

Brain Mechanisms of Poly I:C-Induced Fatigue in Rats

  • Toshihiko Katafuchi
Chapter

Abstract

The clinical symptoms of chronic fatigue syndrome (CFS) have been shown to include disorders in the neuroendocrine, autonomic, and immune systems. On the other hand, it has been demonstrated that cytokines produced in the brain play significant roles in neural-immune interactions through their various central actions, such as activation of the hypothalamo-pituitary axis and sympathetic nervous system. We have recently developed an animal model for fatigue induced by intra-peritoneal (i.p.) injection of synthetic double-stranded RNAs, polyriboinosinic: polyribocytidylic acid (poly I:C, 3 mg/kg), in rats, and shown a decrease in the daily amounts of spontaneous running-wheel activity to about 60% of the preinjection level for more than 1 week. Simultaneously, mRNAs for interferon-α (IFN-α) and serotonin transporter (5-HTT), which is known to be induced by IFN-α, increased for more than a week following poly I:C injection in the same hypothalamic nuclei and cortex. The increased 5-HTT had a functional significance, since in vivo brain microdialysis revealed that an i.p. injection of poly I:C induced a decrease in the extracellular concentration of 5-HT in the prefrontal cortex, which was blocked by a local perfusion with the selective 5-HT re-uptake inhibitor, fluoxetine. Finally the poly I:C-induced fatigue was attenuated by 5-HT1A receptor agonist, but not by 5-HT2, 5-HT3, or dopamine D3 agonists. These findings suggested that the decrease in 5-HT actions on 5-HT1A receptors may at least partly contribute to the poly I:C-induced fatigue.

Keywords

Prefrontal Cortex Chronic Fatigue Syndrome Serotonin Transporter Heat Exposure Chronic Fatigue Syndrome Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Freeman R, Komaroff AL (1997) Does chronic fatigue syndrome involve the autonomic nervous system? 102:357–364Google Scholar
  2. 2.
    Glaser R, Kiecolt-Glaser JK (1998) Stress-associated immune modulation: relevance to viral infections and chronic fatigue syndrome. Am J Med 105:35S–42SPubMedCrossRefGoogle Scholar
  3. 3.
    Whiteside TL, Friberg D (1998) Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 105:27S–34SPubMedCrossRefGoogle Scholar
  4. 4.
    Komaroff AL (2000) The biology of chronic fatigue syndrome [comment]. Am J Med 108:169–171PubMedCrossRefGoogle Scholar
  5. 5.
    Joyce E, Blumenthal S, Wessely S (1996) Memory, attention, and executive function in chronic fatigue syndrome. J Neurol Neurosurg Psychiatr 60:495–503PubMedCrossRefGoogle Scholar
  6. 6.
    Hori T, Katafuchi T, Oka T (2001) Central cytokines: effects on peripheral immunity, inflammation and nociception. In: Ader R, Felten DL, Cohen N (eds) Psychoneuroimmunology. Academic Press, San Diego, pp 517–545Google Scholar
  7. 7.
    Rothwell NJ, Hopkins SJ (1995) Cytokines and the nervous system. II. Actions and mechanisms of action. Trends Neurosci 18:130–136PubMedCrossRefGoogle Scholar
  8. 8.
    Chao CC, DeLaHunt M, Hu S, Close K, Peterson PK (1992) Immunologically mediated fatigue: a murine model. Clin Immunol Immunopathol 64:161–165PubMedCrossRefGoogle Scholar
  9. 9.
    Kozak W, Conn CA, Kluger MJ (1994) Lipopolysaccharide induces fever and depresses locomotor activity in unrestrained mice. Am J Physiol 266:R125–R135PubMedGoogle Scholar
  10. 10.
    Yamamoto T, Newsholme EA (2000) Diminished central fatigue by inhibition of the L-system transporter for the uptake of tryptophan. Brain Res Bull 52:35–38PubMedCrossRefGoogle Scholar
  11. 11.
    Katafuchi T, Kondo T, Yasaka T, Kubo K, Take S, Yoshimura M (2003) Prolonged effects of polyriboinosinic:polyribocytidylic acid on spontaneous running-wheel activity and brain interferon-α mRNA in rats: a model for immunologically induced fatigue. Neuroscience 120:837–845PubMedCrossRefGoogle Scholar
  12. 12.
    Katafuchi T, Kondo T, Take S, Yoshimura M (2005) Enhanced expression of brain interferon-α and serotonin transporter in immunologically induced fatigue in rats. Eur J Neurosci 22:2817–2826PubMedCrossRefGoogle Scholar
  13. 13.
    Akiyama H, Ikeda K, Katoh M, McGeer EG, McGeer PL (1994) Expression of MRP14, 27E10, interferon-α and leukocyte common antigen by reactive microglia in postmortem human brain tissue. J Neuroimmunol 50:195–201PubMedCrossRefGoogle Scholar
  14. 14.
    Yamada T, Horisberger MA, Kawaguchi N, Moroo I, Toyoda T (1994) Immunohistochemistry using antibodies to α-interferon and its induced protein, MxA, in Alzheimer’s and Parkinson’s disease brain tissues. Neurosci Lett 181:61–64PubMedCrossRefGoogle Scholar
  15. 15.
    Tedeschi B, Barrett JN, Keane RW (1986) Astrocytes produce interferon that enhances the expression of H-2 antigens on a subpopulation of brain cells. J Cell Biol 102:2244–2253PubMedCrossRefGoogle Scholar
  16. 16.
    Ledeboer A, Binnekade R, Breve JJ, Bol JG, Tilders FJ, Van Dam AM (2002) Site-specific modulation of LPS-induced fever and interleukin-1β expression in rats by interleukin-10. Am J Physiol 282:R1762–R1772Google Scholar
  17. 17.
    Alexopoulou L, Holt AC, Medzhitov R, Flavell RA (2001) Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732–738PubMedCrossRefGoogle Scholar
  18. 18.
    Blakely RD, Berson HE, Fremeau RT Jr, Caron MG, Peek MM, Prince HK, Bradley CC (1991) Cloning and expression of a functional serotonin transporter from rat brain. Nature 354:66–70PubMedCrossRefGoogle Scholar
  19. 19.
    Austin MC, Bradley CC, Mann JJ, Blakely RD (1994) Expression of serotonin transporter messenger RNA in the human brain. J Neurochem 62:2362–2367PubMedCrossRefGoogle Scholar
  20. 20.
    Hirst WD, Price GW, Rattray M, Wilkin GP (1998) Serotonin transporters in adult rat brain astrocytes revealed by [3H]5-HT uptake into glial plasmalemmal vesicles. Neurochem Int 33:11–22PubMedCrossRefGoogle Scholar
  21. 21.
    Brust P, Friedrich A, Krizbai IA, Bergmann R, Roux F, Ganapathy V, Johannsen B (2000) Functional expression of the serotonin transporter in immortalized rat brain microvessel endothelial cells. J Neurochem 74:1241–1248PubMedGoogle Scholar
  22. 22.
    Morikawa O, Sakai N, Obara H, Saito N (1998) Effects of interferon-α, interferon-γ and cAMP on the transcriptional regulation of the serotonin transporter. Eur J Pharmacol 349:317–324PubMedCrossRefGoogle Scholar
  23. 23.
    Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD (2005) p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 280:15649–15658PubMedCrossRefGoogle Scholar
  24. 24.
    Bel N, Figueras G, Vilaro MT, Sunol C, Artigas F (1997) Antidepressant drugs inhibit a glial 5-hydroxytryptamine transporter in rat brain. 9:1728–1738Google Scholar
  25. 25.
    Kamata M, Higuchi H, Yoshimoto M, Yoshida K, Shimizu T (2000) Effect of single intra-cerebroventricular injection of α-interferon on monoamine concentrations in the rat brain. Eur Neuropsychopharmacol 10:129–132PubMedCrossRefGoogle Scholar
  26. 26.
    Patarca R (2001) Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 933:185–200PubMedGoogle Scholar
  27. 27.
    Davis JM, Weaver JA, Kohut ML, Colbert LH, Ghaffar A, Mayer EP (1998) Immune system activation and fatigue during treadmill running: role of interferon. Med Sci Sports Exerc 30:863–868PubMedCrossRefGoogle Scholar
  28. 28.
    Katafuchi T, Take S, Hori T (1993) Roles of sympathetic nervous system in the suppression of cytotoxicity of splenic natural killer cells in the rat. J Physiol 465:343–357PubMedGoogle Scholar
  29. 29.
    Take S, Mori T, Katafuchi T, Hori T (1993) Central interferon-α inhibits natural killer cytotoxicity through sympathetic innervation. Am J Physiol 265:R453–R459PubMedGoogle Scholar
  30. 30.
    Katafuchi T, Ichijo T, Take S, Hori T (1993) Hypothalamic modulation of splenic natural killer cell activity in rats. J Physiol 471:209–221PubMedGoogle Scholar
  31. 31.
    Take S, Uchimura D, Kanemitsu Y, Katafuchi T, Hori T (1995) Interferon-α acts at the preoptic hypothalamus to reduce natural killer cytotoxicity in rats. Am J Physiol 268: R-1406–R1410Google Scholar
  32. 32.
    Lloyd A, Hickie I, Brockman A, Dwyer J, Wakefield D (1991) Cytokine levels in serum and cerebrospinal fluid in patients with chronic fatigue syndrome and control subjects. J Infect Dis 164:1023–1024PubMedGoogle Scholar
  33. 33.
    Narita M, Nishibami N, Narita N, Yamaguti K, Okado N, Watanabe Y, Kuratsune H (2003) Association between serotonin transporter gene polymorphism and chronic fatigue syndrome. Biochem Biophys Res Commun 311:264–266PubMedCrossRefGoogle Scholar

Copyright information

© Springer 2008

Authors and Affiliations

  • Toshihiko Katafuchi
    • 1
  1. 1.Department of Integrative Physiology, Graduate School of Medical SciencesKyushu UniversityFukuokaJapan

Personalised recommendations